概要
技术资料
Document Type | 产品名称 | Catalog # | Lot # | 语言 |
---|---|---|---|---|
Product Information Sheet | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit | 19684 | 18F92330 or higher | English |
Product Information Sheet | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit for RoboSep™ | 19684RF | 18F92330 or higher | English |
Safety Data Sheet 1 | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit | 19684 | All | English |
Safety Data Sheet 2 | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit | 19684 | All | English |
Safety Data Sheet 1 | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit for RoboSep™ | 19684RF | All | English |
Safety Data Sheet 2 | EasySep™ Direct HLA Crossmatch B Cell Isolation Kit for RoboSep™ | 19684RF | All | English |
数据及文献
Data
Starting with human whole blood from normal healthy donors, the B cell (CD19+) content of the non-lysed final isolated fraction typically ranges from 89 - 99.8% (gated on CD45). In the above example, the B cell (CD19+) content of the lysed whole blood start sample and non-lysed final isolated fraction is 12.3% and 98.4% (gated on CD45), respectively.